Mannkind

"The additional dilution has been a share price expectation killer, that's for sure."

Agreed. My fantasy went from a romantic European vacation for me and my wife to a weekend with grandchildren at a Holiday Inn with a pool.

For those that like to fantasize about 20X returns, the one thing I've never seen fully vetted is the value of technosphere post Afrezza approval. And of courese, the cancer drugs are a bonus.